CG Oncology

Recent news

• Rating change
  Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)
  TipRanks · 2026/8/7
• Rating change
  Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $93
  Market Newswire · 2026/8/17
• Rating change
  Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)
  TipRanks · 2026/8/13
• Rating change
  A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $85 to $108
  Market Newswire · 2026/8/8
• Rating change
  H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $100
  Market Newswire · 2026/7/29
• Rating change
  Analysts' Top Healthcare Picks: Annexon Biosciences (ANNX), CG Oncology, Inc. (CGON)
  TipRanks · 2026/8/7
• Rating change
  Analysts' Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)
  TipRanks · 2026/8/7
• Rating change
  A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $79 to $100
  Market Newswire · 2026/8/7
• Rating change
  CG Oncology, Inc. (CGON) Gets a Buy From Piper Sandler
  TipRanks · 2026/8/7
• Rating change
  Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON), Natera (NTRA) and Pfizer (PFE)
  TipRanks · 2026/6/23
• Rating change
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)
  TipRanks · 2026/7/28
• Rating change
  RBC Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $81
  Market Newswire · 2026/6/30
• Rating change
  Analysts Offer Insights on Healthcare Companies: ATyr Pharma (ATYR) and CG Oncology, Inc. (CGON)
  TipRanks · 2026/7/10
• UBS Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $90
  Market Newswire · 2026/8/21
• Analysts' Top Healthcare Picks: CG Oncology, Inc. (CGON), Opus Genetics (IRD)
  TipRanks · 2026/9/10
• Rating change
  LifeSci Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $108
  Market Newswire · 2026/7/28
• UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)
  TipRanks · 2026/8/20
• Rating change
  Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON), Alnylam Pharma (ALNY) and Connect Biopharma Holdings (CNTB)
  TipRanks · 2026/6/30
• Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85
  Market Newswire · 2026/8/13
• Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating
  Market Newswire · 2026/9/10

Headlines are aggregated automatically and are not independently verified or edited by our team.